Status:
ACTIVE_NOT_RECRUITING
Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients
Lead Sponsor:
Rutger Lalieu
Conditions:
Long COVID
Long COVID-19 Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Post-Covid syndrome, also known as long Covid, is a clinical condition in which patients experience long term symptoms after Covid-19 infection. Treatment options for post-Covid are not effective. The...
Detailed Description
The study design is a prospective observational cohort study. Questionnaires and medical doctor consultations will be used in order to collect all data. All patients treated with HBOT have medical doc...
Eligibility Criteria
Inclusion
- Long COVID patients who are reffered for treatment with hyperbaric oxygen therapy
- Patients are suffering from cognitive symptoms for \>3 months after Covid infection
Exclusion
- Patients who are not able to fill in questionnaires and informed consent.
- Patients who can't read or do not understand the Dutch language
Key Trial Info
Start Date :
February 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06159309
Start Date
February 6 2023
End Date
August 1 2025
Last Update
June 4 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
DVK Hogeveen
Hoogeveen, Drenthe, Netherlands, 7909 AK
2
DVK Geldrop
Geldrop, North Brabant, Netherlands, 5664 HB
3
DVK Waalwijk
Waalwijk, North Brabant, Netherlands, 5141 BM
4
HGC Rijswijk
Rijswijk, South Holland, Netherlands, 2288EG